Treatment of narcolepsy and comorbid conditions

G. Mayer (Schwalmstadt, Germany)

Source: Sleep and Breathing Conference 2021

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Mayer (Schwalmstadt, Germany). Treatment of narcolepsy and comorbid conditions. Sleep and Breathing Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of comorbid insomnia disorder: implications for somatic and mental health
Source: Sleep and Breathing Conference 2021
Year: 2021


Prevalence of anxiety disorder and depression in newly diagnosed obstructive sleep apnea patients
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016


Sleep disorders in COPD and complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Severe asthma, panic disorder and depression
Source: Eur Respir J 2005; 26: Suppl. 49, 8s
Year: 2005

Influence of psychiatric disorders in patients treated with Varenicline.
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017


Does persistent daytime hypersomnolence in CPAP treated patients with OSAS reflect comorbid narcolepsy or restless legs syndrome ?
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Associated sleep disorders
Source: International Congress 2014 – PG13 Assessment of the obstructive sleep apnoea patient
Year: 2014




Sleep disorder in patients receiving hemodialysis
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015


Detection of sleep-related breathing disorders in cardiologic outpatients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016


The association of nocturia with sleep disorders, metabolic and chronic pulmonary conditions
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010


Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome
Source: Eur Respir J 2001; 17: 313-315
Year: 2001



Effects of CPAP treatment on anxiety and depression in patients with OSAS
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017


Sleep disturbances, psychological conditions and severity symptoms during hospitalization due to AECOPD
Source: International Congress 2017 – Airway clearance techniques and respiratory physiotherapy in hospitalized patients
Year: 2017

Prevalence of psychiatric disorders in seriously-ill COPD patients
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Are there any gender differences in presenting symptoms and outcomes in people treated for obstructive sleep apnoea syndrome?
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014

Depressive symptoms and their association with sleep disorders in the Chilean adult population
Source: Virtual Congress 2020 – Management of chronic lung conditions
Year: 2020

Extent of sleep disturbance in patients with neurodegenerative disorders
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Biofeedback for panic disorder in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008